Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|August 27, 2014
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalizationElena Magrini, Alessandra Villa, Francesca Angiolini, et al.
Oncotarget|June 7, 2018
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenograftsFederica Guffanti, Maddalena Fratelli, Monica Ganzinelli, et al.
Nucleic Acids Research|April 5, 2018
Extensive and systematic rewiring of histone post-translational modifications in cancer model systemsRoberta Noberini, Daniela Osti, Claudia Miccolo, et al.
Molecular Cancer Therapeutics|April 28, 2025
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor GrowthHilary A Kenny, Carman Ka Man Ip, Lucy Kelliher, et al.
Cancers|July 9, 2022
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian CancerKristin L M Boylan, Ashley Petersen, Timothy K Starr, et al.
Cell Death & Disease|May 28, 2024
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemnessChiara Battistini, Hilary A Kenny, Melissa Zambuto, et al.
Cell Death and Differentiation|November 30, 2021
Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancerTania Velletri, Carlo Emanuele Villa, Domenica Cilli, et al.
Circulation Research|July 17, 2020
JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier FunctionNikolaos Kakogiannos, Laura Ferrari, Costanza Giampietro, et al.
Circulation Research|December 14, 2017
VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene ExpressionMarco F Morini, Costanza Giampietro, Monica Corada, et al.
Genome Medicine|October 30, 2020
A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancerPietro Lo Riso, Carlo Emanuele Villa, Gilles Gasparoni, et al.
Pageof 6